申请人:GLAXO GROUP LTD
公开号:WO2002050031A1
公开(公告)日:2002-06-27
Compounds of formula (I) or salts or solvates thereof or physiologically functional derivatives thereof are potent binders at the EP4 receptor and are of use in the treatment or prevention of conditions such as a pain, inflammatory, immunological, bone, neurodegenerative or renal disorder.